Health
GlobalData: US medtech market expected to return to normal very quickly – News-Medical.Net
Following the recent quarterly earnings reports for multiple American Medtech companies;
Following the recent quarterly earnings reports for multiple American Medtech companies;James Spencer, Data Scientist at GlobalData, a leading data and analytics company, offers his view on the current approach to reopening America’s economy:When COVID first hit, GlobalData saw huge drops in medtech sales across all non-essential markets in the US. This led to gigantic drops of 50% in the cardiovascular market and 70% in the hip and knee reconstruction markets. Others, such as the in vitro diagn…
-
Business19 hours agoWarning! These ASX 200 shares were just downgraded
-
Business12 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Business12 hours agoThis ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.
-
Business17 hours ago2 monthly payers you’ll want to own in 2025 and beyond